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Unusual thrombus formation in the aorta after apicoaortic conduit for
severe aortic stenosis
Koji Takeda, MD, Goro Matsumiya, MD, Hiroshi Takano, MD, Masahiro Koh, MD, Keiji Iwata, MD, and
Yoshiki Sawa, MD, Osaka, Japan
Conventional valve replacement for aortic valve stenosishas significant operative risks in patients with dense,circumferential calcification of the ascending aorta. Theapicoaortic conduit (AAC) is one of the alternative meth-
ods to eliminate the aortic manipulation. Several reports have dem-
onstrated that a newly constructed double-outlet left ventricle main-
tains normally distributed blood flow throughout the systemic
circulation without any deleterious physiologic effects.1,2 However,
we encountered the case of a patient who had unanticipated thrombus
formation in the aortic arch that might have resulted from fraction-
ation of the cardiac output and stagnation of the blood flow after
construction of the AAC.
Clinical Summary
A 72-year-old woman with a history of diabetes mellitus and chronic
renal insufficiency requiring hemodialysis experienced progressive
dyspnea on exertion. Echocardiography demonstrated severe aortic
stenosis caused by a calcified valve. Cardiac catheterization demon-
strated a pressure gradient of 58 mm Hg across the aortic valve, a
cardiac index of 3.5 L · min1 · m2, and 90% stenosis of the
proximal right coronary artery. Computed tomography showed severe
circumferential aortic calcification of the whole aorta, including the
aortic root.
To preclude the aortic valve procedure through a median sternot-
omy, we inserted the AAC through the left thoracotomy. The thoracic
cavity was entered through the sixth intercostal space, and cardiopul-
monary bypass was initiated with distal descending aortic cannulation
and right femoral venous drainage. The patient was kept normother-
mic, and a 20-mm Hemashield graft (Meadox, Hemashield; Boston
Scientific, Boston, Mass) was sewn to the descending aorta during
side clamping. Continuous infusion of -blocker was started, and the
heart rate was decreased to around 30 beats/min. In a head-down
position, the left ventricular apex was enucleated with a 20-mm coring
knife. The valved conduit incorporating a 23-mm stentless valve
(Edwards Prima Plus; Stentless Bioprosthesis, Inc, Irvine, Calif) and
a 20-mm Hemashield graft was anastomosed with the apical hole. The
2 parts of the conduit were then anastomosed. A saphenous vein graft
placed from the coronary orifice of the stentless valve was grafted to
the right coronary artery concomitantly.
The postoperative course was uncomplicated, and the patient had
improvement of symptoms. Computed tomography at 1 month after
the operation demonstrated unobstructed conduit (Figure 1) and un-
expected thrombus formation, possibly caused by stagnation of blood
flow in the aortic arch (Figure 2). Administration of sodium warfarin
was initiated immediately, and no thromboembolic events have been
observed.
Discussion
Recent modifications of the technique and innovation of the technol-
ogy has made it more feasible to accomplish the AAC for various
omplex lesions of the left ventricular outflow tract not easily ame-
nable to other techniques.3,4 In our case creation of an AAC combined
with coronary revascularization was successfully performed with a
pharmacologically controlled beating heart, which is a new and less-
invasive procedure even with the support of cardiopulmonary bypass.
Furthermore, the use of a stentless bioprosthesis enabled us to obtain
a larger valve orifice and to avoid anticoagulation. The patient was
freed from heart failure symptoms, and postoperative computed to-
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doi:10.1016/j.jtcvs.2006.02.044 Figure 1. Postoperative computed tomography after apicoaortic
conduit insertion demonstrated an unobstructed conduit.
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mography demonstrated unobstructed conduit without any sign of
intraconduit thrombus.
There have been concerns about the fractionation of the cardiac
output after construction of the AAC. Few previous studies have
demonstrated that blood flow is distributed normally throughout the
systemic and coronary circulation, and no deleterious effects have
resulted from fractionation of the cardiac output into the antegrade
(native outflow) and retrograde (conduit) portions.1,2 However, recent
experiences with a left ventricular assist system, which bypasses the
left ventricle and the descending aorta, have shown the stagnation of
blood flow in the ascending aorta and the resultant massive myocar-
dial infarction from coronary artery occlusion in a few patients. 5 The
same scenario could take place in the patients receiving an AAC. The
flow through the conduit depends on the degree of the native left
ventricular outflow tract obstruction in relation to the conduit size and
its inherent impedance.1 In the present case preoperative cardiac
output was relatively preserved (cardiac index of 3.5 L · min1 ·
m2). Therefore the antegrade flow after construction of the AAC
might have been maintained in relation to the retrograde flow, and that
has led to stagnation of the bloodstream and the subsequentf thrombus
formation in the aortic arch. Although the patient had no embolic
events, further predominance of retrograde flow might have caused a
cerebral infarction. In this point of view, close observation of the
thrombus formation in the aorta and postoperative anticoagulation
therapy might be warranted after the AAC, even in patients who
received biologic valves.
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Figure 2. Axial (A) and sagittal (B) view of the thrombus formation (arrow) in the aortic arch after apicoaortic
conduit insertion.
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